Market closed
Quanterix/$QTRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Quanterix
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Ticker
$QTRX
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
471
Website
Quanterix Metrics
BasicAdvanced
$241M
-
-$1.00
1.34
-
Price and volume
Market cap
$241M
Beta
1.34
52-week high
$22.59
52-week low
$6.16
Average daily volume
747K
Financial strength
Current ratio
8.656
Quick ratio
7.648
Long term debt to equity
9.882
Total debt to equity
11.323
Management effectiveness
Return on assets (TTM)
-7.42%
Return on equity (TTM)
-11.33%
Valuation
Price to revenue (TTM)
1.734
Price to book
0.73
Price to tangible book (TTM)
0.73
Price to free cash flow (TTM)
-6.183
Growth
Revenue change (TTM)
12.30%
Earnings per share change (TTM)
33.15%
3-year revenue growth (CAGR)
7.52%
3-year earnings per share growth (CAGR)
-13.34%
What the Analysts think about Quanterix
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Quanterix stock.
Quanterix Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Quanterix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Quanterix News
AllArticlesVideos
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
Business Wire·4 days ago
Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Quanterix Releases Financial Results for the Fourth Quarter of 2024
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Quanterix stock?
Quanterix (QTRX) has a market cap of $241M as of April 05, 2025.
What is the P/E ratio for Quanterix stock?
The price to earnings (P/E) ratio for Quanterix (QTRX) stock is 0 as of April 05, 2025.
Does Quanterix stock pay dividends?
No, Quanterix (QTRX) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Quanterix dividend payment date?
Quanterix (QTRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Quanterix?
Quanterix (QTRX) has a beta rating of 1.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.